Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma

By Yang Xiaoya   Xiong Gang   Chen Xuedan   Xu Xueqing   Wang Kai   Fu Yong   Yang Kang   Bai Yun  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 10, 2009-10 ,pp. : 1341-1349

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Significance of GPR56, Transglutaminase 2, and NF-κB in Esophageal Squamous Cell Carcinoma

By Kausar Tasneem   Sharma Rinu   Hasan Md. Raghibul   Tripathi Satyendra Chandra   Saraya Anoop   Chattopadhyay Tushar K.   Gupta Siddartha Datta   Ralhan Ranju  

Cancer Investigation, Vol. 29, Iss. 1, 2011-01 ,pp. : 42-48

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice

By          

Oncology Reports, Vol. 28, Iss. 1, 2012-01 ,pp. : 232-240

Spandidos Publications

Access to resources Recommend Favorite

Promoter methylationassociated silencing of p27kip1 gene with metastasis in esophageal squamous cell carcinoma

By                

Molecular Medicine Reports, Vol. 9, Iss. 3, 2014-01 ,pp. : 1075-1079

Spandidos Publications

Access to resources Recommend Favorite

Correlation among 16 biological factors [p53, p21waf1, MIB1 (Ki67), p16INK4A, cyclin D1, Ecadherin, Bcl2, TNFα, NFκB, TGFβ, MMP7, COX2, EGFR, HER2/neu, ER, and HIF1α] and clinical outcomes following curative chemoradiation therapy in 10 patients with esophageal squamous cell carcinoma

By              

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 903-910

Spandidos Publications

Access to resources Recommend Favorite